755037-03-7 | Regorafenib (Catalog# : 52722)Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFR, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respe
704869-38-5 | SUN11602 (Catalog# : 17030603)SUN11602 is a novel aniline compound, which mimics the neuroprotective mechanisms of basic fibroblast growth factor. In primary cultures of rat cerebrocortical neurons, SUN11602
745833-23-2 | VX-702 (Catalog# : 16070804)VX-702, one of a series of second-generation, is an orally active p38 MAP kinase inhibitors, for the potential treatment of inflammation, rheumatoid arthritis and cardiovascular
725247-18-7 | XCT790 (Catalog# : 16071016)XCT790 is a potent and specific inverse agonist of ERR. XCT790 shows no significant antagonist activity on related nuclear receptors, such as ERR or ER at concentrations below 10
781613-23-8 | XL647 (Catalog# : 111301)XL647 is an orally bioavailable small-molecule receptor tyrosine kinase inhibitor with potential antineoplastic activity; inhibits EGFR, HER2, VEGFR and EphB4 kinase.